Evalution of Iron Species in Healthy Subjects treated with Generic and Reference Sodium Ferric Gluconate
This study is part of post-market surveillance on approved generic products, which can help address potential concerns regarding the quality of generic iron complex products and support the Agencys review standards.
Detailed Descriptions:
A prospective, randomized, 2-way crossover study to compare plasma TI, TBI, NTBI levels in healthy subjects treated with generic and reference sodium ferric gluconate injections is preferred. Utilize in vitro and in vivo biomarkers such as malondialdehyde, heme-oxygenase-1 (HO-1) RNA or others to evaluate the oxidative stress and toxicity caused by generic and RLD products.
1. Colle...
Source: Grants.gov - April 18, 2014 Category: Research Tags: Health Science and Technology and other Research and Development Source Type: funding
Limited Competition: Chronic Kidney Disease (CKD) Biomarkers Consortium Data Coordinating Center (U01)
Funding Opportunity Number: RFA-DK-13-506 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-NIH11Closing Date: Nov 27, 2013Award Ceiling: Expected Number of Awards: Creation Date: Aug 02, 2013Funding Opportunity Description: The Chronic Kidney Disease Biomarkers Consortium [CKD BioCon] was established in September 2009 as a result of RFA-DK-08-015 [Chronic...
Source: Grants.gov - August 3, 2013 Category: Research Tags: Food and Nutrition Health Source Type: funding
Limited Competition: Chronic Kidney Disease (CKD) Biomarkers Consortium Data Coordinating Center (U01)
Funding Opportunity RFA-DK-13-506 from the NIH Guide for Grants and Contracts. The Chronic Kidney Disease Biomarkers Consortium [CKD BioCon] was established in September 2009 as a result of RFA-DK-08-015 [Chronic Kidney Disease Biomarker Discovery and Validation Consortium (U01)] to develop, validate and qualify biomarkers based on existing biosamples from well-characterized CKD patients with longitudinal follow-up. The CKD BioCon consists of six Participating Centers (PCs) and is actively engaged in multiple research protocols. The initial Funding Opportunity Announcement to establish the Consortium did not provide...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 2, 2013 Category: Research Source Type: funding
United States Renal Data System (USRDS) Special Study Centers (U01)
Funding Opportunity Number: RFA-DK-13-008 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits ha...
Source: Grants.gov - May 25, 2013 Category: Research Tags: Food and Nutrition Health Source Type: funding
United States Renal Data System (USRDS) Special Study Centers (U01)
Funding Opportunity RFA-DK-13-008 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Division of Kidney, Urologic and Hematologic Diseases (DKUHD) wishes to fund approximately two or three Special Studies Centers (SSCs) that will work with United States Renal Data System (USRDS) to carry out biomedical or economic studies in late stage Chronic Kidney Disease (CKD) or dialysis patients. Each SSC will design, pilot, and conduct at least one special study during the grant period and also analyze existing datasets. The USRDS Coordinating Center will ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 22, 2013 Category: Research Source Type: funding
Planning Grants for Translating CKD Research into Improved Clinical Outcomes (R34)
Funding Opportunity Number: RFA-DK-13-002 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3)...
Source: Grants.gov - April 18, 2013 Category: Research Tags: Food and Nutrition Health Source Type: funding
Planning Grants for Translating CKD Research into Improved Clinical Outcomes (R34)
Funding Opportunity RFA-DK-13-002 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) encourages NIH Clinical Trial Planning Grant (R34) applications from institutions/organizations to assess the feasibility of testing the effectiveness of interventions for the prevention, treatment and management of chronic kidney disease that have a high likelihood of being widely adopted and sustained in a wide range of health care settings and in individuals and communities at highest risk. The approaches to be tested must be based on widely accepted intervent...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2013 Category: Research Source Type: funding
